AI assistant
Sending…
Moderna, Inc. — Director's Dealing 2024
Oct 4, 2024
30610_dirs_2024-10-04_a10e6e37-084c-4a54-a3a4-70ee95909d1d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2024-10-02
Reporting Person: Hussain Abbas (Director)
More from Moderna, Inc.
Regulatory Filings
2026
May 11
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 23
Annual Report
2026
Feb 20
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13